Low rates of acute and chronic GVHD with ATG and PTCy in matched and mismatched unrelated donor peripheral blood stem cell transplants
Shruti Prem(University Health Network), Auro Viswabandya(Princess Margaret Cancer Centre), Jeffrey H. Lipton(Princess Margaret Cancer Centre), David Loach(University Health Network), Rajat Kumar(University Health Network), Arjun Law(University of Toronto), Santhosh Thyagu(Princess Margaret Cancer Centre), Eshetu G. Atenafu(Princess Margaret Cancer Centre), Fotios V. Michelis(Princess Margaret Cancer Centre), Zeyad Al‐Shaibani(University Health Network), Wilson Lam(Princess Margaret Cancer Centre), Dennis Kim(Princess Margaret Cancer Centre)
Cited by 43
Related Papers
BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia
|Cancer Cell|2014|366
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib
|Leukemia|2008|354
Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study
|Annals of Oncology|2019|282
A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy
|Oncotarget|2017|187
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors
|Biology of Blood and Marrow Transplantation|2015|142